Veracyte Inc logo

VCYT - Veracyte Inc News Story

$46.91 -8.5  -15.3%

Last Trade - 04/03/21

Sector
Healthcare
Size
Mid Cap
Market Cap £2.26bn
Enterprise Value £2.01bn
Revenue £84.6m
Position in Universe 1752nd / 6647

BRIEF-Veracyte And Yale Announce Exclusive License To Advance First Genomic Monitoring Test For Idiopathic Pulmonary Fibrosis

Thu 23rd April, 2020 1:24pm
April 23 (Reuters) - Veracyte Inc  VCYT.O :
    * VERACYTE AND YALE ANNOUNCE EXCLUSIVE LICENSE TO ADVANCE
FIRST
GENOMIC MONITORING TEST FOR IDIOPATHIC PULMONARY FIBROSIS

Source text for Eikon:  ID:nBw3hH69ka 
Further company coverage:  VCYT.O 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.